105 related articles for article (PubMed ID: 36345808)
41. Feasibility of dynamic adaptive passive scattering proton therapy with computed tomography image guidance in the lung.
Moriya S; Tachibana H; Hotta K; Nakamura N; Sakae T; Akimoto T
Med Phys; 2017 Sep; 44(9):4474-4481. PubMed ID: 28665491
[TBL] [Abstract][Full Text] [Related]
42. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
[TBL] [Abstract][Full Text] [Related]
43. Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes.
Cubillos-Mesías M; Baumann M; Troost EGC; Lohaus F; Löck S; Richter C; Stützer K
Radiat Oncol; 2017 Nov; 12(1):190. PubMed ID: 29183377
[TBL] [Abstract][Full Text] [Related]
44. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
[TBL] [Abstract][Full Text] [Related]
45. Small spot size versus large spot size: Effect on plan quality for lung cancer in pencil beam scanning proton therapy.
Rana S; Rosenfeld AB
J Appl Clin Med Phys; 2022 Feb; 23(2):e13512. PubMed ID: 34989458
[TBL] [Abstract][Full Text] [Related]
46. Motion effects in proton treatments of hepatocellular carcinoma-4D robustly optimised pencil beam scanning plans versus double scattering plans.
Pfeiler T; Ahmad Khalil D; Ayadi M; Bäumer C; Blanck O; Chan M; Engwall E; Geismar D; Peters S; Plaude S; Spaan B; Timmermann B; Wulff J
Phys Med Biol; 2018 Nov; 63(23):235006. PubMed ID: 30468685
[TBL] [Abstract][Full Text] [Related]
47. Range optimization for target and organs at risk in dynamic adaptive passive scattering proton beam therapy - A proof of concept.
Moriya S; Tachibana H; Hotta K; Nakamura N; Sakae T; Akimoto T
Phys Med; 2018 Dec; 56():66-73. PubMed ID: 30527091
[TBL] [Abstract][Full Text] [Related]
48. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
[TBL] [Abstract][Full Text] [Related]
49. Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images.
Kurz C; Nijhuis R; Reiner M; Ganswindt U; Thieke C; Belka C; Parodi K; Landry G
Radiat Oncol; 2016 Apr; 11():64. PubMed ID: 27129305
[TBL] [Abstract][Full Text] [Related]
50. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
[TBL] [Abstract][Full Text] [Related]
51. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
Koivula L; Wee L; Korhonen J
Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
[TBL] [Abstract][Full Text] [Related]
52. Single line source with and without vaginal loading and the impact on target coverage and organ at risk doses for cervix cancer Stages IB, II, and IIIB: treatment planning simulation in patients treated with MRI-guided adaptive brachytherapy in a multicentre study (EMBRACE).
Nkiwane KS; Pötter R; Tanderup K; Federico M; Lindegaard JC; Kirisits C
Brachytherapy; 2013; 12(4):317-23. PubMed ID: 23474352
[TBL] [Abstract][Full Text] [Related]
53. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
54. 4D Proton treatment planning strategy for mobile lung tumors.
Kang Y; Zhang X; Chang JY; Wang H; Wei X; Liao Z; Komaki R; Cox JD; Balter PA; Liu H; Zhu XR; Mohan R; Dong L
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):906-14. PubMed ID: 17293240
[TBL] [Abstract][Full Text] [Related]
55. Multiple anatomy optimization of accumulated dose.
Watkins WT; Moore JA; Gordon J; Hugo GD; Siebers JV
Med Phys; 2014 Nov; 41(11):111705. PubMed ID: 25370619
[TBL] [Abstract][Full Text] [Related]
56. Energy layer optimization strategies for intensity-modulated proton therapy of lung cancer patients.
Jensen MF; Hoffmann L; Petersen JBB; Møller DS; Alber M
Med Phys; 2018 Oct; 45(10):4355-4363. PubMed ID: 30129041
[TBL] [Abstract][Full Text] [Related]
57. ALERT-RA: an aperture library-enabled real-time respiratory motion adaptive framework for 4D-VMAT.
Christiansen EJ; Xu T; Heath E
Med Phys; 2022 Nov; 49(11):6774-6793. PubMed ID: 36166687
[TBL] [Abstract][Full Text] [Related]
58. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
[TBL] [Abstract][Full Text] [Related]
59. A planning study of focal dose escalations to multiparametric MRI-defined dominant intraprostatic lesions in prostate proton radiation therapy.
Wang T; Zhou J; Tian S; Wang Y; Patel P; Jani AB; Langen KM; Curran WJ; Liu T; Yang X
Br J Radiol; 2020 Mar; 93(1107):20190845. PubMed ID: 31904261
[TBL] [Abstract][Full Text] [Related]
60. Feasibility study: spot-scanning proton arc therapy (SPArc) for left-sided whole breast radiotherapy.
Chang S; Liu G; Zhao L; Dilworth JT; Zheng W; Jawad S; Yan D; Chen P; Stevens C; Kabolizadeh P; Li X; Ding X
Radiat Oncol; 2020 Oct; 15(1):232. PubMed ID: 33028378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
